Latest News and Press Releases

Mechelen, België; 9 juni 2026, 22:01 CET; gereglementeerde informatie – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) heeft vandaag de start aangekondigd van een aandeleninkoopprogramma...

Mechelen, Belgium; June 8, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that Eric Hedrick, MD has been appointed Chief Medical Officer. This expanded...

Mechelen, België; 8 juni 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) heeft vandaag bekendgemaakt dat Eric Hedrick, MD, is benoemd tot Chief Medical Officer. Deze...

Companies will collaborate on the development of gamgertamig, a potential first-in-class and best-in-class T cell engager in autoimmune diseases Foster City, Calif. and Mechelen, Belgium; June 4,...

Bedrijven gaan samenwerken aan de ontwikkeling van gamgertamig, een potentieel first-in-class en best-in-class T-cel-engager voor auto-immuunziekten Foster City, Californië en Mechelen, België; 4...

ASSEMBLÉE GÉNÉRALE MIXTE ET CONSEIL D’ADMINISTRATION DU 27 MAI 2026 Communiqué de presse Paris, le 27 mai 2026 Assemblée générale mixte L’Assemblée générale des actionnaires de Société Générale...

COMBINED GENERAL MEETING AND BOARD OF DIRECTORS DATED 27 MAY 2026 Press release Paris, 27 May 2026 Combined General Meeting The General Meeting of shareholders of Societe Generale was held on 27...

Mechelen, Belgium; May 26, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Bank of America. Pursuant to...

Mechelen, België; 26 mei 2026, 22.01 CET; gereglementeerde informatie – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) heeft een transparantieverklaring ontvangen van Bank of America. ...

Financing led by Sofinnova Investments and co-led by Forbion and Novo Holdings Proceeds to advance lead immunology program COL-5671, a potential first-in-class, oral once-daily therapy, across a...